NCIC Clinical Trials Group

πŸ‡¨πŸ‡¦Canada
Ownership
Private
Employees
-
Market Cap
-
Website

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Phase 3
Completed
Conditions
First Posted Date
2004-04-09
Last Posted Date
2020-04-03
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
227
Registration Number
NCT00003232
Locations
πŸ‡¨πŸ‡¦

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor, Ontario, Canada

πŸ‡¨πŸ‡¦

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada

πŸ‡¨πŸ‡¦

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada

and more 18 locations

Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2004-04-08
Last Posted Date
2023-08-21
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
850
Registration Number
NCT00080912
Locations
πŸ‡¨πŸ‡¦

CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada

πŸ‡¨πŸ‡¦

The Vitalite Health Network - Dr. Leon Richard, Moncton, New Brunswick, Canada

πŸ‡¨πŸ‡¦

Allan Blair Cancer Centre, Regina, Saskatchewan, Canada

and more 9 locations

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

First Posted Date
2004-03-25
Last Posted Date
2020-04-06
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
14
Registration Number
NCT00006036
Locations
πŸ‡¨πŸ‡¦

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada

πŸ‡¨πŸ‡¦

British Columbia Cancer Agency, Vancouver, British Columbia, Canada

πŸ‡¨πŸ‡¦

Toronto General Hospital, Toronto, Ontario, Canada

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

First Posted Date
2004-03-09
Last Posted Date
2023-08-23
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
849
Registration Number
NCT00078949
Locations
πŸ‡¨πŸ‡¦

Allan Blair Cancer Centre, Regina, Saskatchewan, Canada

πŸ‡ΊπŸ‡Έ

Indiana University Medical Center, Indianapolis, Indiana, United States

πŸ‡ΊπŸ‡Έ

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

and more 24 locations

Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor

Phase 2
Completed
Conditions
First Posted Date
2004-03-09
Last Posted Date
2023-08-04
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
34
Registration Number
NCT00079079
Locations
πŸ‡¨πŸ‡¦

Princess Margaret Hospital, Toronto, Ontario, Canada

πŸ‡¨πŸ‡¦

CancerCare Manitoba, Winnipeg, Manitoba, Canada

πŸ‡¨πŸ‡¦

London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada

and more 1 locations

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Phase 1
Completed
Conditions
First Posted Date
2004-03-09
Last Posted Date
2023-08-04
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
19
Registration Number
NCT00079053
Locations
πŸ‡¨πŸ‡¦

CHUM - Hopital Notre-Dame, Montreal, Canada

πŸ‡¨πŸ‡¦

London Regional Cancer Program, London, Canada

Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer

Phase 3
Completed
Conditions
First Posted Date
2004-03-09
Last Posted Date
2023-08-04
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
572
Registration Number
NCT00079066
Locations
πŸ‡¨πŸ‡¦

Hopital Charles Lemoyne, Greenfield Park, Quebec, Canada

πŸ‡¨πŸ‡¦

Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada

πŸ‡¨πŸ‡¦

Hopital Du Sacre-Coeur de Montreal, Montreal, Quebec, Canada

and more 30 locations

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

First Posted Date
2004-03-08
Last Posted Date
2020-04-02
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
67
Registration Number
NCT00006890
Locations
πŸ‡ΊπŸ‡Έ

St. Mary's/Duluth Clinic Health System, Duluth, Minnesota, United States

πŸ‡¨πŸ‡¦

Saint John Regional Hospital, Saint John, New Brunswick, Canada

πŸ‡¨πŸ‡¦

Moncton Hospital, Moncton, New Brunswick, Canada

and more 61 locations

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

First Posted Date
2004-02-26
Last Posted Date
2020-04-06
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
81
Registration Number
NCT00010179
Locations
πŸ‡¨πŸ‡¦

Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada

πŸ‡¨πŸ‡¦

BCCC - Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada

πŸ‡¨πŸ‡¦

Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada

and more 11 locations

Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

Phase 3
Completed
Conditions
Interventions
First Posted Date
2004-02-16
Last Posted Date
2020-04-03
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
555
Registration Number
NCT00003011
Locations
πŸ‡¨πŸ‡¦

British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada

πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

πŸ‡¨πŸ‡¦

British Columbia Cancer Agency, Vancouver, British Columbia, Canada

and more 35 locations
Β© Copyright 2024. All Rights Reserved by MedPath